KIAA1191: A Potential Drug Target for Various Diseases (G57179)

Target Name: KIAA1191

NCBI ID: G57179

KIAA1191: A Potential Drug Target for Various Diseases

KIAA1191 (KIAA1191 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the KIAA family of proteins, which are known for their role in cell signaling.

Recent studies have identified KIAA1191 as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the reasons for the interest in KIAA1191 is its role in the development and progression of cancer. Several studies have shown that KIAA1191 is highly expressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, experiments have shown that inhibiting KIAA1191 can lead to the inhibition of cancer cell growth and the inhibition of the formation of new blood vessels that can contribute to the growth and progression of cancer.

Another potential application of KIAA1191 as a drug target is its role in neurodegenerative diseases. Research has shown that KIAA1191 is involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, studies have shown that inhibiting KIAA1191 can lead to the improvement of neurodegenerative diseases symptoms, such as cognitive function and motor activity.

KIAA1191 has also been shown to be involved in autoimmune disorders. Research has shown that KIAA1191 is involved in the development and progression of autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. Additionally, studies have shown that inhibiting KIAA1191 can lead to the improvement of autoimmune disorders symptoms, such as joint tenderness and swelling.

In conclusion, KIAA1191 is a protein that has been shown to be involved in a variety of diseases and conditions. Its potential as a drug target or biomarker makes it an attractive target for further research and development. Further studies are needed to fully understand the role of KIAA1191 in disease progression and to determine its potential as a drug.

Protein Name: KIAA1191

Functions: Potential NADPH-dependent oxidoreductase. May be involved in the regulation of neuronal survival, differentiation and axonal outgrowth

More Common Targets